Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07456878) titled 'Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas' on March 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Mayo Clinic

Condition: Pituitary Adenoma

Intervention: Drug: FET-PET/MRI

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: January 8, 2026

Target Sample Size: 5

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07456878

Published by HT Digital Content ...